University of Wisconsin Foundation
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), University of Wisconsin Foundation reported 9 stock positions worth $126.3 million. Its top holding was Vaneck Semiconductor ETF (SMH) at 22.8% of the portfolio, followed by Cerebras Systems Class A (CBRS, 14.9%) and Pearl Diver Credit Compy (PDCC, 11.5%). Compared with Q1 2026, it opened 2 new positions, sold out of 3, added to 1 and reduced 3. The biggest buy was a new position in Vaneck Semiconductor ETF (SMH) and the biggest sale an exit from Sea Ltd.-ADR (SE).
- Most Recent 13F
- Q2 2026
- Location
- MADISON, WI
- CIK
- 0001697228
- Portfolio Value
- $126.3M (Q2 2026)
- SEC Filing
- 0001697228-26-000005 ↗ filed Aug 14, 2026
Holdings Value
Holdings 9 stocks · $126.3M
| SMH Vaneck Semiconductor ETF | 22.77% | 43,838 | $28.8M | New |
| CBRS Cerebras Systems Inc. Class A | 14.86% | 84,911 | $18.8M | New |
| PDCC Pearl Diver Credit Compy Inc. | 11.51% | 1,459,021 | $14.5M | No change |
| PCVX Vaxcyte Inc. | 11.03% | 239,749 | $13.9M | No change |
| NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD | 10.86% | 1,026,765 | $13.7M | No change |
| PRAX Praxis Precision Medicines I | 9.21% | 34,730 | $11.6M | Add +37.7% |
| AAPL Apple Inc. | 7.14% | 31,153 | $9.0M | Reduce -26.4% |
| GOOGL Alphabet Inc. Class A | 7.12% | 25,154 | $9.0M | Reduce -29.7% |
| DYN Dyne Therapeutics Inc. | 5.51% | 313,559 | $7.0M | Reduce -35.3% |
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $126.3M | SMH, CBRS, PDCC, PCVX, NU |
| Q1 2026 | 10 | $112.6M | PDCC, NU, PCVX, AAPL, SE |
| Q4 2025 | 8 | $118.9M | NU, PDCC, AAPL, NVDA, MSFT |
| Q3 2025 | 9 | $118.1M | PDCC, NU, AKRO, RNAM, NVDA |
| Q2 2025 | 5 | $89.4M | PDCC, NU, AKRO, MDGL, ETNB |
| Q1 2025 | 8 | $117.8M | SE, PDCC, MDGL, NU, AKRO |
| Q4 2024 | 7 | $137.6M | SE, PDCC, IVV, NU, MDGL |
| Q3 2024 | 7 | $153.3M | SE, IVV, PDCC, NU, AKRO |
| Q2 2024 | 6 | $88.8M | IVV, NU, MDGL, GE, AKRO |
| Q1 2024 | 6 | $88.6M | IVV, NU, MDGL, GE, AKRO |